Bauknecht T - Search Results

1

Clinical phase I study with one-hour paclitaxel infusion.

Mross K, Hauns B, Häring B, Bauknecht T, Meerpohl HG, Unger C, Maier-Lenz H. Mross K, et al. Among authors: bauknecht t. Ann Oncol. 1998 May;9(5):569-72. doi: 10.1023/a:1008217429971. Ann Oncol. 1998. PMID: 9653500 Free article. Clinical Trial.

2

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. Among authors: bauknecht t. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

3

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer.

du Bois A, Lück HJ, Bauknecht T, Möbus V, Bochtler H, Diergarten K, Meerpohl HG. du Bois A, et al. Among authors: bauknecht t. Ann Oncol. 1997 Apr;8(4):355-61. doi: 10.1023/a:1008267419453. Ann Oncol. 1997. PMID: 9209665 Free article. Clinical Trial.

4

Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics.

Maier-Lenz H, Hauns B, Haering B, Koetting J, Mross K, Unger C, Bauknecht T, du Bois A, Meerpohl HG, Hollaender N, Diergarten K. Maier-Lenz H, et al. Among authors: bauknecht t. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-16-S19-19. Semin Oncol. 1997. PMID: 9427259 Clinical Trial.

5

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy.

du Bois A, Schlaich M, Lück HJ, Mollenkopf A, Wechsel U, Rauchholz M, Bauknecht T, Meerpohl HG. du Bois A, et al. Among authors: bauknecht t. Support Care Cancer. 1999 Sep;7(5):354-61. doi: 10.1007/s005200050275. Support Care Cancer. 1999. PMID: 10483822

6

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer.

Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K, et al. Meerpohl HG, et al. Among authors: bauknecht t. Semin Oncol. 1995 Dec;22(6 Suppl 15):7-12. Semin Oncol. 1995. PMID: 8643973 Clinical Trial.

7

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial.

Meerpohl HG, du Bois A, Luck HJ, Kühnle H, Möbus V, Kreienberg R, Bauknecht T, Köchli O, Bochtler H, Diergarten K. Meerpohl HG, et al. Among authors: bauknecht t. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-17-S2-22. Semin Oncol. 1997. PMID: 9045330 Clinical Trial.

8

Phase II study of gemcitabine in ovarian cancer.

von Minckwitz G, Bauknecht T, Visseren-Grul CM, Neijt JP. von Minckwitz G, et al. Among authors: bauknecht t. Ann Oncol. 1999 Jul;10(7):853-5. doi: 10.1023/a:1008364327684. Ann Oncol. 1999. PMID: 10470434 Free article. Clinical Trial.

9

Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer.

du BA, Meier W, Lück HJ, Emon G, Moebus V, Schroeder W, Costa S, Bauknecht T, Olbricht S, Jackisch C, Richter B, Wagner U. du BA, et al. Among authors: bauknecht t. Ann Oncol. 2002 Feb;13(2):251-7. doi: 10.1093/annonc/mdf038. Ann Oncol. 2002. PMID: 11886002 Free article. Clinical Trial.

10

First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.

du Bois A, Lück HJ, Bauknecht T, Meier W, Richter B, Kuhn W, Quaas J, Pfisterer J. du Bois A, et al. Among authors: bauknecht t. J Clin Oncol. 1999 Jan;17(1):46-51. doi: 10.1200/JCO.1999.17.1.46. J Clin Oncol. 1999. PMID: 10458217 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page